Drugdiscovery >> Drugs >> News
8460
Views
SOLIAIR™: New Respiratory Diseases Drug Discovery! - drugdiscovery.com
SOLIAIR™: New Respiratory Diseases Drug Discovery! - drugdiscovery.com


SOLIAIR™ is a food supplement which has reported beneficial impact. Patients taking SOLIAIR™ reported a decrease in seasonal infections of the respiratory tract. The SOLIAIR™ is free of side effects!
Read More >>


Tags: Drug Development,Drug Discovery,Medicine Development,COPD Treatment,Asthma Solution,Bronchitis Therapy,Respiratory Diseases,Lung Infections,Breathing Disorders,healthcare investment,Drug Innovation, - November 1, 2013
Related Articles
1635
Views
Quo Vadis Drug Discovery? - a Book review Quo Vadis Drug Discovery? - a Book review
The Future of Drug Discovery: Who decides which diseases to treat? is an outstanding book, written by Tamas Bartfai and Graham V. Lees. According to the workers of pharmaceutical trade, it provides a Read More >>

Tags: drug discovery, book, review, future

5720
Views
Zebularine: old drug, new use Zebularine: old drug, new use
An old cancer drug, Zebularine, developed in the U.S. in the 1960s, has shown an unexpected effect on the immune system, which may open a new avenue for its use in the development of new treatments f Read More >>

Tags: zebularine, cancer drug, immune system, tissue rejection, transplantation, autoimmune diseases, autoimmune reaction, cytidine deaminase inhibitor, DNA methylation inhibitor

3864
Views
Generic version of Antara is announced Generic version of Antara is announced
Dr. Reddy’s Laboratories announced the generic version of Antara. Fenofibrate Capsules are used to treat Primary Hypercholesterolemia and Mixed Dyslipidemia. Read More >>

Tags: Primary Hypercholesterolemia, Mixed Dyslipidemia, Fenofibrate Capsules, drug discovery, generic drugs, generig drug marketing

3344
Views
Primary blood pressure drug can delay the development of mental diseases Primary blood pressure drug can delay the development of mental diseases
scientists of Brighton University say that a common blood pressure drug might help to fight dementia. ACE inhibitors are now seem to be able to make dementia slower and less harmful. Read More >>

Tags: Ace inhibitors, dementia, dementia treatment, mental disease

3325
Views
Blood pressure drugs plus allergy - it might even be lethal Blood pressure drugs plus allergy - it might even be lethal
Several common blood pressure drugs can be a lethal combo for if you suffer from certain type of allergy. Doctors warn us to pay attention to side effects which might be difficult to find. Read More >>

Tags: drug discovery, doctors, blood pressure drugs, allergy, side effect

6365
Views
New Drug Application for Delcath's drug rejected New Drug Application for Delcath's drug rejected
The FDA has issued a complete response letter (CRL) regarding the New Drug Application (NDA) for Delcath Systems’ drug MelblezTM Kit, for the treatment of patients with unresectable ocular melanoma Read More >>

Tags: new drug application, NDA, Delcath, ocular melanoma, drug, Melblez, melphalan

13484
Views
Orphan Drug Designation for Hemophilia B drug ALN-AT3 Orphan Drug Designation for Hemophilia B drug ALN-AT3
FDA has approved an Orphan Drug Designation to Alnylam Pharmaceuticals’ drug ALN-AT3 for the treatment of hemophilia B. ALN AT3 is subcutaneously administered RNAi therapeutic which targets antith Read More >>

Tags: orphan drug, ALN-AT3, hemophilia B, antithrombin, RNAi,Alnylam

8470
Views
Orphan Drug Designation for HPV-associated anal cancer drug - ADXS-HPV Orphan Drug Designation for HPV-associated anal cancer drug - ADXS-HPV
FDA has approved an Orphan Drug Designation to Advaxis’ next generation immunotherapy drug ADXS-HPV for the treatment of human papillomavirus (HPV)-associated anal cancer. Read More >>

Tags: Advaxis, ADXS-HPV, HPV, anal cancer, human papillomavirus, immunotherapy, drug

7003
Views
Thetanix, orphan drug for pediatric Crohn's disease Thetanix, orphan drug for pediatric Crohn's disease
The FDA has granted Orphan Drug Designation to GT Biologics for its drug Thetanix (bacteroides thetaiotaomicron) for paediatric Crohn’s disease. Read More >>

Tags: paediatric, Crohn’s disease, children, drug, orphan drug, Thetanix, GT Biologic

10575
Views
Another Sanofi MS drug approved in EU Another Sanofi MS drug approved in EU
After Aubagio, Lemtrada - another Sanofi’s drug for treatment of multiple sclerosis has been approved by the European Commission. Read More >>

Tags: multiple sclerosis, Europe, new drug, Aubagio, Lemtrada

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013